Active, not recruitingPhase 3NCT05210790
A Phase 3 Study of Rusfertide in Patients With Polycythemia Vera
Studying Polycythemia vera
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Protagonist Therapeutics, Inc.
- Intervention
- Placebo(drug)
- Enrollment
- 293 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2022 – 2027
Study locations (30)
- Infirmary Cancer Care, Mobile, Alabama, United States
- Palo Verde Hematology-Oncology, Glendale, Arizona, United States
- City of Hope Medical Center, Duarte, Duarte, California, United States
- California Cancer Associates for Research and Excellence - Fresno, Fresno, California, United States
- Marin Cancer Care, Greenbrae, California, United States
- City of Hope Medical Center, Lenner, Irvine, California, United States
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla, California, United States
- University of California, Los Angeles (UCLA) - Medical Center, Los Angeles, California, United States
- Stanford University, Palo Alto, California, United States
- Pomona Valley Hospital Medical Center, Pomona, California, United States
- Sharp Memorial Hospital, San Diego, California, United States
- University of California, San Francisco, San Francisco, California, United States
- City of Hope Medical Center, Upland, Upland, California, United States
- Rocky Mountain Cancer Centers, Aurora, Colorado, United States
- University of Colorado - Aurora Cancer Center, Aurora, Colorado, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05210790 on ClinicalTrials.govOther trials for Polycythemia vera
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07362225MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)MPN Research Foundation
- RECRUITINGPHASE2NCT07232290Phase IIa Study on Flonoltinib Maleate Tablets in the Treatment of Patients With Polycythemia VeraChengdu Zenitar Biomedical Technology Co., Ltd
- RECRUITINGPHASE2NCT06985147A Phase 2, Open-Label Study of DISC-3405 in Participants With Polycythemia Vera (PV)Disc Medicine, Inc
- RECRUITINGNCT06743035Ropeginterferon Alfa-2b in Patients With Polycythemia Vera (PV) Without Symptomatic SplenomegalyiOMEDICO AG
- RECRUITINGNCT06752941LOW-PV ContinuationFROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
- RECRUITINGPHASE3NCT06093672Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia VeraItalfarmaco
- RECRUITINGPHASE1NCT06752746A Study of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of 9MW3011 in Patients With Polycythemia VeraMabwell (Shanghai) Bioscience Co., Ltd.
- ACTIVE NOT RECRUITINGPHASE3NCT06033586Study to Evaluate the Long-term Safety of Rusfertide (PTG-300) in Subjects With Polycythemia VeraProtagonist Therapeutics, Inc.